An ASX biotech formerly worth over $500 million has lost most of its value after its drug failed to treat lung cancer effectively.

The parent company of Optus says it remains committed to Australia by providing a critical service and has apologised for the fatal triple-zero outage.

Experts have suggested measures that could prevent a repeat of a horror crash that killed five people after a diabetic driver became hypoglycaemic.

From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories' leading brand, is strengthening the robustness of its clinical studies via data augmentation ...

Singtel board director Gail Kelly is expected to face a grilling at a parliamentary inquiry into Optus' fatal triple-zero outage. The September 18 outage, which lasted almost 14 hours, affected ...

As more Australians live beyond 90, aged care providers must adapt care models to support frailty, dementia and quality of life for the ...

Tens of thousands of people are leaving hospital before finishing emergency treatment despite having potentially life-threatening conditions, health data..

Roche shares have dropped after its oral breast cancer drug giredestrant failed to show benefits in a key phase III clinical trial.

A second royal commission into New Zealand's pandemic response has found "scars" were left by the government's handling of COVID-19, but on the whole it was "considered and appropriate". Kiwis were ...

A nursing home where almost half of its residents died after contracting COVID-19 during the height of the pandemic has been convicted and fined over five years after the tragedy. St Basil's Home for ...